If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Regulatory News (ABDN)

Share Price Information for Abrdn (ABDN)

Share Price is delayed by 15 minutes
Get Live Data
244.60    -7.80 (-3.09%)
Bid:
244.40
Ask:
244.60
Spread: 0.20 (0.082%)
Market Cap: £4.38b
ABDN Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Share Chart

Director/PDMR Shareholding

17 Nov 2025 10:50

RNS Number : 8102H
Aberdeen Group PLC
17 November 2025
 

Aberdeen Group plc

(the 'Company')

Notification of Interests of Executive Director

The notification set out below is provided under Article 19 of the Market Abuse Regulation ('MAR').

On 14 November 2025, the Company granted to Siobhan Boylan the following awards ('Buyout Awards') to compensate for remuneration she forfeited on leaving her previous employer.

The Buyout Awards were structured as conditional awards to acquire ordinary shares in the Company and were granted under a one-off award arrangement established under UK Listing Rule 9.3.2(2) in order to facilitate the recruitment of Ms Boylan.

The vesting timelines are the same as those which applied to the forfeited awards.

Further details will be disclosed in the Company's Directors' Remuneration Report for the year ending 31 December 2025.

Awards have been made in the form of conditional awards to acquire ordinary shares in the Company which are subject to time-based vesting.

The Awards will normally vest on the dates shown below and vested awards are subject to a holding period of one year. After this date they are released, and the shares are transferred.

Award

Number of Aberdeen Group plc shares awarded

Normal Vesting Date

2023 Deferred Bonus Award (bought-out)

5,491

7 March 2026

2023 Deferred Bonus Award (bought-out)

5,491

7 March 2027

2023 Deferred Bonus Award (bought-out)

5,491

7 March 2028

2023 Deferred Bonus Award (bought-out)

5,491

7 March 2029

2024 Deferred Bonus Award (bought-out)

12,542

7 March 2028

2024 Deferred Bonus Award (bought-out)

12,542

7 March 2029

2024 Deferred Bonus Award (bought-out)

12,542

7 March 2030

2024 Deferred Bonus Award (bought-out)

12,542

7 March 2031

2024 Deferred Bonus Award (bought-out)

12,531

7 March 2032

 

No consideration is payable on the grant or vesting of any of the Awards. The number of shares to which each Award relates will be increased by an additional number of shares equal in value to any dividends that would have been paid on the shares in respect of which the Award is released, over the period from the vesting date to the release date.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Siobhan Boylan

2.

Reason for the notification

a)

Position/ status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aberdeen Group plc

b)

LEI

0TMBS544NMO7GLCE7H90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification Code

Ordinary Shares of 13 61/63 pence each in Aberdeen Group plc

GB00BF8Q6K64

b)

Nature of transaction

Grant of conditional awards to facilitate the recruitment of Ms Boylan made under a one-off award arrangement established under UK Listing Rule 9.3.2(2)

c)

Price(s) and volume(s)

 

Price

Volume

Nil

5,491

Nil

5,491

Nil

5,491

Nil

5,491

Nil

12,542

Nil

12,542

Nil

12,542

Nil

12,542

Nil

12,531

 

 

d)

Aggregated information

- Aggregated volume

- Total Price

 

84,663 shares

Nil

e)

Date of the transaction

14 November 2025

f)

Place of the transaction 

Outside a trading venue

 

17 November 2025

Enquiries:

Group Secretariat

Iain Jones

 

+44 (0) 7464 917 797 

Media Relations

Duncan Young

 

 

+44 (0) 7920 868 865 

Institutional Equity Investors

Duncan Heath

 

+44 (0) 207 156 2495

 

LEI number of Aberdeen Group plc: 0TMBS544NMO7GLCE7H90

Classification: 3.1. Additional regulated information required to be disclosed under the laws of the United Kingdom

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSILSLDLIE
Date   Source Headline
12th Feb 20261:17 pmRNSForm 8.3 - LondonMetric Property PLC
12th Feb 202611:50 amRNSForm 8.3 - International Personal Finance PLC
12th Feb 202611:45 amRNSForm 8.3 - British Land Co PLC, The
11th Feb 20269:58 amRNSForm 8.3 - British Land Co PLC, The
10th Feb 202611:31 amRNSForm 8.3 - British Land Co PLC, The
5th Feb 20261:52 pmRNSForm 8.3 Oxford Biomedica plc
3rd Feb 20261:48 pmRNSHolding(s) in Company
3rd Feb 202612:23 pmRNSForm 8.3 - Bluefield Solar Income Fund Limited
3rd Feb 202612:19 pmRNSForm 8.3 - Oxford Biomedica PLC
3rd Feb 202612:14 pmRNSForm 8.3 - International Personal Finance PLC
3rd Feb 202612:10 pmRNSForm 8.3 - British Land Co PLC, The
3rd Feb 202612:06 pmRNSForm 8.3 - Picton Property Income Limited
2nd Feb 202610:10 amRNSTotal Voting Rights
29th Jan 20261:39 pmRNSHolding(s) in Company
29th Jan 202612:19 pmRNSForm 8.3 - British Land Co PLC, The
29th Jan 202612:13 pmRNSForm 8.3 - Life Science REIT PLC
29th Jan 202612:04 pmRNSForm 8.3 - Auction Technology Group plc
28th Jan 20263:49 pmRNSHolding(s) in Company
28th Jan 202612:11 pmRNSForm 8.3 - Unite Group plc/The
28th Jan 202612:08 pmRNSForm 8.3 - Oxford Biomedica PLC
26th Jan 20261:25 pmRNSForm 8.3 - Unite Group plc, The
26th Jan 202612:01 pmRNSForm 8.3 - Picton Property Income Limited
26th Jan 202611:58 amRNSForm 8.3 - JTC plc
26th Jan 202611:53 amRNSForm 8.3 - International Personal Finance plc
22nd Jan 202610:55 amRNSForm 8.3 - JTC plc
21st Jan 202612:12 pmRNSForm 8.3 - Unite Group plc, The
21st Jan 202612:05 pmRNSForm 8.3 - Oxford Biomedica plc
21st Jan 202612:01 pmRNSForm 8.3 - JTC plc
21st Jan 20267:00 amRNSQ4 2025 AUMA and Flows Trading Update
19th Jan 20261:04 pmRNSHolding(s) in Company
19th Jan 202611:59 amRNSForm 8.3 - UNITE Group PLC/The
19th Jan 202611:56 amRNSForm 8.3 - Picton Property Income Limited
19th Jan 202611:48 amRNSForm 8.3 - Oxford Biomedica plc
19th Jan 202611:41 amRNSForm 8.3 - JTC PLC
19th Jan 202611:37 amRNSForm 8.3 - International Personal Finance PLC
19th Jan 202611:34 amRNSForm 8.3 - Empiric Student Property PLC
19th Jan 202611:27 amRNSForm 8.3 - Bluefield Solar Income Fund Limited
16th Jan 20269:43 amRNSForm 8.3 - UNITE Group PLC/The
16th Jan 20269:32 amRNSForm 8.3 - Oxford Biomedica plc
16th Jan 20269:25 amRNSForm 8.3 - International Personal Finance PLC
15th Jan 20269:21 amRNSForm 8.3 - Oxford Biomedica plc
14th Jan 20261:33 pmRNSForm 8.3 - Unite Group plc, The
14th Jan 20261:29 pmRNSForm 8.3 - Picton Property Income Limited (OPD)
14th Jan 20261:26 pmRNSForm 8.3 - JTC plc
14th Jan 20267:00 amRNSDirector Declaration
12th Jan 202611:03 amRNSForm 8.3 - JTC plc
9th Jan 202610:39 amRNSForm 8.3 - Unite Group PLC/The
9th Jan 202610:38 amRNSForm 8.3 - JTC plc
9th Jan 202610:36 amRNSForm 8.3 - Empiric Student Property plc
8th Jan 202610:03 amRNSForm 8.3 - Unite Group PLC/The

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.